Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Moyer

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
American Journal of Health Behavior|December 13, 2005
Iqmik: a form of smokeless tobacco used among Alaska nativesCaroline C Renner, Carrie Enoch, Christi A Patten, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 13, 2006
Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agentsBrad W Wilkins, Christiane Hesse, Hans P Sviggum, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 4, 2014
Stone composition as a function of age and sexJohn C Lieske, Andrew D Rule, Amy E Krambeck, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 17, 2007
Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco usersJon O Ebbert, Lowell C Dale, Christi A Patten, et al.
Clinical Chemistry|August 27, 2002
Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profilesThomas P Moyer, Joel R Charlson, Robert J Enger, et al.
Journal of the American College of Cardiology|April 13, 2010
Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study)Robert S Epstein, Thomas P Moyer, Ronald E Aubert, et al.
Clinical Chemistry|February 26, 2003
National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency departmentAlan H B Wu, Charles McKay, Larry A Broussard, et al.
Therapeutic Drug Monitoring|November 25, 2010
Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxineDonald E McAlpine, Joanna M Biernacka, David A Mrazek, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 9, 2005
Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonatesRichard D Hurt, Caroline C Renner, Christi A Patten, et al.
Mayo Clinic Proceedings|December 4, 2009
Warfarin sensitivity genotyping: a review of the literature and summary of patient experienceThomas P Moyer, Dennis J O'Kane, Linnea M Baudhuin, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
American Journal of Health Behavior|December 13, 2005
Iqmik: a form of smokeless tobacco used among Alaska nativesCaroline C Renner, Carrie Enoch, Christi A Patten, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 13, 2006
Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agentsBrad W Wilkins, Christiane Hesse, Hans P Sviggum, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 4, 2014
Stone composition as a function of age and sexJohn C Lieske, Andrew D Rule, Amy E Krambeck, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 17, 2007
Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco usersJon O Ebbert, Lowell C Dale, Christi A Patten, et al.
Clinical Chemistry|August 27, 2002
Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profilesThomas P Moyer, Joel R Charlson, Robert J Enger, et al.
Journal of the American College of Cardiology|April 13, 2010
Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study)Robert S Epstein, Thomas P Moyer, Ronald E Aubert, et al.
Clinical Chemistry|February 26, 2003
National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency departmentAlan H B Wu, Charles McKay, Larry A Broussard, et al.
Therapeutic Drug Monitoring|November 25, 2010
Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxineDonald E McAlpine, Joanna M Biernacka, David A Mrazek, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 9, 2005
Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonatesRichard D Hurt, Caroline C Renner, Christi A Patten, et al.
Mayo Clinic Proceedings|December 4, 2009
Warfarin sensitivity genotyping: a review of the literature and summary of patient experienceThomas P Moyer, Dennis J O'Kane, Linnea M Baudhuin, et al.
Pageof 3